MYXMAYNE PHARMA GROUP LIMITEDMarket sensitive

Mayne Pharma reports unaudited Q4 and FY26 results

Date and time
Announcement type
Periodic Reports

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case